5324 articles
Dirk Huebner, MD, Chief Medical Officer at Aptevo Therapeutics, a biotech company, discusses the company's focus on bringing novel immuno-oncology thera...
Rakesh Amin, MD, discusses the toll that schizophrenia takes on caregivers, how caregivers of schizophrenia patients can best support themselves, as wel...
Hema Tallman, SVP and Global Head of BioLife Plasma Services at Takeda, an industry leader in the collection of high-quality plasma and a supporting dri...
David Bearss, PhD, President and CEO at Halia Therapeutics, a clinical-stage biopharma company developing novel therapies to improve the lives of patien...
Schizophrenia is a serious and complex mental illness that left untreated can disrupt a person's relationships, physical health, and plans for the futur...
Mark McDonough, CEO of ChromaCode, a molecular diagnostics company, discusses how ChromaCode technology provides a cost-effective, rapid, and accurate...
Amelia Korangy, Director of External Affairs Strategy and Programs at ViiV Healthcare - the only pharmaceutical company solely focused on HIV, discusses...
Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...
Greg Pierce, SVP and GM of Specialty, Health & Wellness at Synchrony, a financial services company, discusses the over-the-counter (OTC) hearing aids ru...
federal government designated May 11, 2023, as the official end of the COVID-19 health emergency in the U.S. Learn more on Health Professional Radio.